Cargando…
Tumor volume shrinkage during stereotactic body radiotherapy is related to better prognoses in patients with stage I non-small-cell lung cancer
The purpose of the study was to investigate the association between tumor volume changes during stereotactic body radiation therapy (SBRT) and prognoses in stage I non-small-cell lung cancer (NSCLC). This retrospective review included stage I NSCLC patients in whom SBRT was performed at a total dose...
Autores principales: | Vu, Nam, Onishi, Hiroshi, Saito, Masahide, Kuriyama, Kengo, Komiyama, Takafumi, Marino, Kan, Araya, Masayuki, Aoki, Shinichi, Saito, Ryo, Nonaka, Hotaka, Funayama, Satoshi, Watanabe, Hiroaki, Sano, Naoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482165/ https://www.ncbi.nlm.nih.gov/pubmed/32657333 http://dx.doi.org/10.1093/jrr/rraa040 |
Ejemplares similares
-
Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation Therapy
por: Funayama, Satoshi, et al.
Publicado: (2019) -
Modified Glasgow Prognostic Score is predictive of prognosis for non-small cell lung cancer patients treated with stereotactic body radiation therapy: a retrospective study
por: Chen, Zhe, et al.
Publicado: (2021) -
Impact of Systemic Autoimmune Diseases on Treatment Outcomes and Radiation Toxicities in Patients with Stage I Non-Small Cell Lung Cancer Receiving Stereotactic Body Radiation Therapy: A Matched Case-Control Analysis
por: Chen, Zhe, et al.
Publicado: (2022) -
Serious gastric perforation after second stereotactic body radiotherapy for peripheral lung cancer that recurred after initial stereotactic body radiotherapy: a case report
por: Nonaka, Hotaka, et al.
Publicado: (2017) -
Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity
por: Onishi, Hiroshi, et al.
Publicado: (2020)